Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Safer liver test could predict deadly bleeding

NCT ID NCT04633356

Summary

This study is testing a new, potentially safer method to measure pressure inside the liver (portal hypertension) in people with cirrhosis from chronic hepatitis. The goal is to see if this new method, done during a standard scope exam, can accurately predict a patient's risk of serious complications like internal bleeding. Researchers will enroll 30 patients to see how well the new technique works compared to the current, more difficult standard.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chinese University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.